Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723Aexternal-prioritypatent/DE10233723A1/en
Application filed by Bayer Schering Pharma AGfiledCriticalBayer Schering Pharma AG
Priority claimed from PCT/EP2003/008111external-prioritypatent/WO2004011663A2/en
Publication of AU2003281677A1publicationCriticalpatent/AU2003281677A1/en
Assigned to BAYER SCHERING PHARMA AKTIENGESELLSCHAFTreassignmentBAYER SCHERING PHARMA AKTIENGESELLSCHAFTAlteration of Name(s) of Applicant(s) under S113Assignors: SCHERING AKTIENGESELLSCHAFT
Application grantedgrantedCritical
Publication of AU2003281677B2publicationCriticalpatent/AU2003281677B2/en
Preparation of 7 alpha-substituted 11 alpha-hydroxy-steroids, useful as precursors for new androgenic 7 alpha,17 alpha-substituted 11 beta-halo-steroids, by microbiological conversion of 7 alpha-substituted steroids